GoodRx Holdings, Inc. Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GoodRx Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • GoodRx Holdings, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $18.2M.
  • GoodRx Holdings, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $65.8M.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2024 was $65.8M.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2023 was -$27M, a 1654% decline from 2022.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2022 was $1.74M, a 87% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $65.8M +$92.9M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$27M -$28.7M -1654% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $1.74M -$11.7M -87% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $13.4M +$289M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$276M -$415M -297% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $140M +$62.4M +80.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $77.3M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.